CIRCULATING IMMUNE DYNAMICS DURING NEOADJUVANT CHEMOIMMUNOTHERAPY IN EARLY TRIPLE-NEGATIVE BREAST CANCER
Background: Pathological complete response (pCR) after pembrolizumab-based neoadjuvant chemoimmunotherapy predicts improved outcomes in early triple-negative breast cancer (TNBC), but circulating immune determinants of response remain poorly characterized. Methods: The study included 64 patients with early TNBC treated with pembrolizumab-based neoadjuvant chemoimmunotherapy. Flow cytometry analyzed 125 peripheral-blood specimens collected at baseline, during treatment and before surgery. Baseline PBMCs from 22 patients underwent scRNA-seq, generating 135,271 quality-controlled cells. Analyses used nonparametric tests, effect sizes, FDR correction and sensitivity analyses. Results: Baseline scRNA-seq identified response-associated transcriptional differences. Patient-level pseudo-bulk analysis revealed enrichment of TNF-alpha/NF-kappaB signaling in cytotoxic T/NK and B cells from non-pCR patients (global q<=3.94e-7), together with MYC targets and mTORC1 signaling in cytotoxic T/NK cells (both global q=7.00e-5). T-cell analyses suggested preserved naive/memory features in pCR, while a higher proportion of CX3CR1-expressing cells within the CD4 memory/activation-like compartment was associated with pCR (q=0.0157; AUC=0.949). In B cells, pCR was associated with a nominally higher naive-like program score (P=0.029; q=0.059), supported by higher IGHM and IGHD signals, whereas XBP1 was higher in non-pCR. Flow cytometry identified treatment-associated B-cell remodeling. At pre-surgery, switched-memory B-cell CD38 balance was higher in pCR than non-pCR patients (62.6% versus 50.0%; P=0.0086; q=0.0667; Cliff's delta=0.651; AUC=0.825) and remained nominally significant in leave-one-patient-out analyses. Early increases in unswitched-memory B-cell CD38 balance were numerically greater in non-pCR patients, whereas pre-surgery switched-memory B-cell CD38 balance was higher in pCR patients. Conclusions: Baseline inflammatory and metabolic pathway enrichment was associated with non-pCR, whereas pCR-associated T-cell findings included a CD4 memory/activation-associated CX3CR1 signal and trends towards preserved naive/memory features. Together with time- and compartment-dependent B-cell remodeling, these findings nominate circulating transcriptional states and CD38-defined B-cell dynamics for prospective validation as candidate biomarkers of pathological response.
Authors
- Javier Pascual (ORCID: https://orcid.org/0000-0003-3874-2782)
- Rafael López‐López (ORCID: https://orcid.org/0000-0002-2240-6277)
- Jesús Velasco-Suelto
- Clotilde Costa (ORCID: https://orcid.org/0000-0001-7327-2259)
- Maria Rosario Chica-Parrado
- María Victoria Ortega-Jiménez (ORCID: https://orcid.org/0000-0001-8657-1098)
- M.I. Hierro-Martín (ORCID: https://orcid.org/0000-0002-7291-443X)
- Martina Álvarez (ORCID: https://orcid.org/0000-0002-0303-2871)
- María Elena Quirós-Ortega (ORCID: https://orcid.org/0000-0001-7725-6168)
- Enríque Álava (ORCID: https://orcid.org/0009-0001-6796-7780)
- Esperanza López-López
- Patricia Palacios Ozores (ORCID: https://orcid.org/0000-0003-0410-079X)
- Roberto Piñeiro (ORCID: https://orcid.org/0000-0001-9479-139X)
- Begoña Jiménez-Rodríguez
- Iñaki Comino‐Méndez (ORCID: https://orcid.org/0000-0003-1926-9432)
- Álvaro González-Ortiz
- María Emilia Domínguez
- Antonia Márquez
- B. Pajares
- Ana Godoy
- Emilio Alba
- Patricia Chaves-Guerrero
- Nuria Ribelles
- Pilar Cantizani
Institutions
- Complejo Hospitalario Universitario de Santiago (ES)
- Hospital Regional Universitario de Málaga (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Andalusian Centre for Nanomedicine and Biotechnology (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Servicio Gallego de Salud (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Sevilla (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.19.26368490
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- preprint
Funders
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación
- European Social Fund